Brain,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 20, 2024
Abstract
Treating
cognitive
impairment
is
a
holy
grail
of
modern
clinical
neuroscience.
In
the
past
few
years,
non-invasive
brain
stimulation
increasingly
emerging
as
therapeutic
approach
to
ameliorate
performance
in
patients
with
and
an
augmentation
persons
whose
within
normal
limits.
Alzheimer’s
disease,
better
understanding
connectivity
function
has
allowed
for
development
different
protocols.
Recent
studies
have
shown
that
transcranial
methods
enhancing
plasticity
several
modalities
beneficial
effects
on
functions.
Amelioration
been
preclinical
behaviour
transgenic
mouse
models
pathology
variable
severity
impairment.
While
field
still
grappling
issues
related
standardization
target
population,
frequency,
intensity,
treatment
duration
stimulated
region,
positive
outcomes
reported
functions
markers
pathology.
Here
we
review
most
encouraging
protocols
based
repetitive
magnetic
stimulation,
direct
current
alternating
visual-auditory
photobiomodulation
focused
ultrasound,
which
demonstrated
efficacy
enhance
or
slow
decline
disease.
Beneficial
are
associated
modulation
specific
networks.
The
promising
results
obtained
targeting
key
hubs
higher-level
networks,
such
frontal-parietal
network
default
mode
network.
personalization
parameters
according
individual
features
sheds
new
light
optimizing
future
applications.
Trends in Cognitive Sciences,
Journal Year:
2022,
Volume and Issue:
27(2), P. 189 - 205
Published: Dec. 19, 2022
Transcranial
alternating
current
stimulation
(tACS)
can
modulate
human
neural
activity
and
behavior.
Accordingly,
tACS
has
vast
potential
for
cognitive
research
brain
disorder
therapies.
The
generates
oscillating
electric
fields
in
the
that
bias
spike
timing,
causing
changes
local
oscillatory
power
cross-frequency
cross-area
coherence.
affects
performance
by
modulating
underlying
single
or
nested
rhythms,
distal
synchronization,
metabolic
activity.
Clinically,
tailored
to
abnormal
oscillations
shows
promising
results
alleviating
psychiatric
neurological
symptoms.
We
summarize
findings
of
mechanisms,
its
use
applications,
novel
developments
personalized
stimulation.
Clinical Neurophysiology,
Journal Year:
2023,
Volume and Issue:
150, P. 131 - 175
Published: March 30, 2023
The
review
provides
a
comprehensive
update
(previous
report:
Chen
R,
Cros
D,
Curra
A,
Di
Lazzaro
V,
Lefaucheur
JP,
Magistris
MR,
et
al.
clinical
diagnostic
utility
of
transcranial
magnetic
stimulation:
report
an
IFCN
committee.
Clin
Neurophysiol
2008;119(3):504-32)
on
stimulation
(TMS)
in
neurological
diseases.
Most
TMS
measures
rely
motor
cortex
and
recording
evoked
potentials.
Paired-pulse
techniques,
incorporating
conventional
amplitude-based
threshold
tracking,
have
established
neurodegenerative,
movement,
episodic
(epilepsy,
migraines),
chronic
pain
functional
Cortical
hyperexcitability
has
emerged
as
aid
amyotrophic
lateral
sclerosis.
Single-pulse
are
stroke,
myelopathy
even
the
absence
radiological
changes.
Short-latency
afferent
inhibition,
related
to
central
cholinergic
transmission,
is
reduced
Alzheimer's
disease.
triple
technique
(TST)
may
enhance
detect
upper
neuron
involvement.
potentials
can
be
used
perform
mapping
or
preoperative
assessment
eloquent
brain
regions
before
surgical
resection
tumors.
exhibits
assessing
lumbosacral/cervical
nerve
root
function,
especially
demyelinating
neuropathies,
localizing
site
facial
palsies.
also
high
sensitivity
detecting
subclinical
corticospinal
lesions
multiple
Abnormalities
conduction
time
TST
correlate
with
impairment
disability
MS.
Cerebellar
cerebellum
cerebello-dentato-thalamo-motor
cortical
pathways.
Combining
electroencephalography,
novel
method
measure
parameters
altered
disorders,
including
excitability,
effective
connectivity,
response
complexity.
Exploration,
Journal Year:
2024,
Volume and Issue:
4(5)
Published: March 14, 2024
Abstract
Neural
interfaces,
emerging
at
the
intersection
of
neurotechnology
and
urban
planning,
promise
to
transform
how
we
interact
with
our
surroundings
communicate.
By
recording
decoding
neural
signals,
these
interfaces
facilitate
direct
connections
between
brain
external
devices,
enabling
seamless
information
exchange
shared
experiences.
Nevertheless,
their
development
is
challenged
by
complexities
in
materials
science,
electrochemistry,
algorithmic
design.
Electrophysiological
crosstalk
mismatch
electrode
rigidity
tissue
flexibility
further
complicate
signal
fidelity
biocompatibility.
Recent
closed‐loop
brain‐computer
while
promising
for
mood
regulation
cognitive
enhancement,
are
limited
accuracy
adaptability
user
interfaces.
This
perspective
outlines
challenges
discusses
progress
contrasting
non‐invasive
invasive
approaches,
explores
dynamics
stimulation
interfacing.
Emphasis
placed
on
applications
beyond
healthcare,
highlighting
need
implantable
high‐resolution
capabilities.
Brain stimulation,
Journal Year:
2023,
Volume and Issue:
16(3), P. 748 - 755
Published: April 5, 2023
Highlights•40
Hz
tACS
enhances
gamma
oscillations
and
memory
performance
in
MCI/AD
patients.•Active
40
increases
spectral
power
patients
over
sham.•Gamma
stimulation
may
aid
clearance
of
tau
mouse
models
AD
patients.AbstractBackgroundTranscranial
alternating
current
(tACS)—a
noninvasive
brain
technique
that
modulates
cortical
through
entrainment—has
been
demonstrated
to
alter
oscillatory
activity
enhance
cognition
healthy
adults.
TACS
is
being
explored
as
a
tool
improve
patient
populations
with
mild
cognitive
impairment
(MCI)
Alzheimer's
disease
(AD).ObjectiveTo
review
the
growing
body
literature
findings
obtained
from
application
MCI
or
AD,
highlighting
effects
on
function,
memory,
cognition.
Evidence
use
animal
also
discussed.
Important
parameters
are
underscored
for
consideration
protocols
aim
apply
therapeutic
MCI/AD.FindingsThe
has
shown
promising
results
improvement
processes
impacted
MCI/AD.
These
data
demonstrate
potential
an
interventional
stand-alone
alongside
pharmacological
and/or
other
behavioral
interventions
MCI/AD.ConclusionsWhile
evidenced
encouraging
results,
this
function
pathophysiology
remains
be
fully
determined.
This
explores
highlights
need
continued
research
course
by
reinstating
activity,
improving
processing,
delaying
progression,
remediating
abilities
Neuropsychology Review,
Journal Year:
2023,
Volume and Issue:
34(1), P. 338 - 361
Published: March 6, 2023
Abstract
Despite
the
numerous
pharmacological
interventions
targeting
dementia,
no
disease-modifying
therapy
is
available,
and
prognosis
remains
unfavorable.
A
promising
perspective
involves
tackling
high-frequency
gamma-band
(>
30
Hz)
oscillations
involved
in
hippocampal-mediated
memory
processes,
which
are
impaired
from
early
stages
of
typical
Alzheimer’s
Disease
(AD).
Particularly,
positive
effects
entrainment
on
mouse
models
AD
have
prompted
researchers
to
translate
such
findings
into
humans
using
transcranial
alternating
current
stimulation
(tACS),
a
methodology
that
allows
endogenous
cortical
frequency-specific
manner.
This
systematic
review
examines
state-of-the-art
use
gamma-tACS
Mild
Cognitive
Impairment
(MCI)
dementia
patients
shed
light
its
feasibility,
therapeutic
impact,
clinical
effectiveness.
search
two
databases
yielded
499
records
resulting
10
included
studies
total
273
patients.
The
results
were
arranged
single-session
multi-session
protocols.
Most
demonstrated
cognitive
improvement
following
gamma-tACS,
some
showed
neuropathological
markers,
suggesting
feasibility
these
anyhow
far
strong
evidence
available
for
models.
Nonetheless,
small
number
their
wide
variability
terms
aims,
parameters,
measures,
make
it
difficult
draw
firm
conclusions.
We
discuss
methodological
limitations
studies,
proposing
possible
solutions
future
avenues
improve
research
dementia.
The
neuropathological
features
of
Alzheimer's
disease
include
amyloid
plaques.
Rapidly
emerging
evidence
suggests
that
Piezo1,
a
mechanosensitive
cation
channel,
plays
critical
role
in
transforming
ultrasound-related
mechanical
stimuli
through
its
trimeric
propeller-like
structure,
but
the
importance
Piezo1-mediated
mechanotransduction
brain
functions
is
less
appreciated.
However,
apart
from
stimulation,
Piezo1
channels
are
strongly
modulated
by
voltage.
We
assume
may
play
converting
and
electrical
signals,
which
could
induce
phagocytosis
degradation
Aβ,
combined
effect
stimulation
superior
to
single
stimulation.
Hence,
we
design
transcranial
magneto-acoustic
(TMAS)
system,
based
on
ultrasound
(TUS)
within
magnetic
field
combines
coupling
electric
force
ultrasound,
applied
it
test
above
hypothesis
5xFAD
mice.
Behavioral
tests,
vivo
electrophysiological
recordings,
Golgi-Cox
staining,
enzyme-linked
immunosorbent
assay,
immunofluorescence,
immunohistochemistry,
real-time
quantitative
PCR,
Western
blotting,
RNA
sequencing,
cerebral
blood
flow
monitoring
were
used
assess
whether
TMAS
can
alleviate
symptoms
AD
mouse
model
activating
Piezo1.
treatment
enhanced
autophagy
promote
β-amyloid
activation
microglial
alleviated
neuroinflammation,
synaptic
plasticity
impairment,
neural
oscillation
abnormalities
mice,
showing
stronger
than
ultrasound.
inhibition
with
an
antagonist,
GsMTx-4,
prevented
these
beneficial
effects
TMAS.
This
research
indicates
transform
TMAS-related
into
biochemical
signals
identifies
favorable
mice
mediated
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 24, 2024
Abstract
The
gradual
shifting
of
preferred
neural
spiking
relative
to
local
field
potentials
(LFPs),
known
as
phase
precession,
plays
a
prominent
role
in
coding.
Correlations
between
the
precession
and
behavior
have
been
observed
throughout
various
brain
regions.
As
such,
is
suggested
be
global
mechanism
that
promotes
neuroplasticity.
However,
causal
evidence
neuroplastic
mechanisms
are
lacking
so
far.
Here
we
show
link
LFP
dynamics
precession.
In
three
experiments,
modulated
LFPs
humans,
non-human
primate,
computational
models
using
alternating
current
stimulation.
We
continuous
stimulation
motor
cortex
oscillations
humans
lead
shift
maximal
corticospinal
excitability
by
~90°.
Further,
exogenous
induced
subset
entrained
neurons
(~30%)
primate.
Multiscale
modeling
realistic
circuits
suggests
stimulation-induced
driven
NMDA-mediated
synaptic
plasticity.
Altogether,
experiments
provide
mechanistic
for
neocortical
process.
Alternating
current-induced
consequently
plasticity
crucial
development
novel
therapeutic
neuromodulation
methods.
Clinical Neurophysiology,
Journal Year:
2024,
Volume and Issue:
158, P. 159 - 169
Published: Jan. 4, 2024
To
evaluate
the
effects
of
cerebellar
transcranial
alternating
current
stimulation
(tACS)
delivered
at
cerebellar-resonant
frequencies,
i.e.,
theta
(θ)
and
gamma
(γ),
on
upper
limb
motor
performance
cerebellum-primary
cortex
(M1)
connectivity,
as
assessed
by
cerebellar-brain
inhibition
(CBI),
in
healthy
subjects.
Participants
underwent
cerebellar-tACS
while
performing
three
cerebellar-dependent
tasks:
(i)
rhythmic
finger-tapping,
(ii)
arm
reaching-to-grasp
('grasping')
(iii)
reaching-to-point
('pointing')
an
object.
Also,
we
evaluated
possible
changes
CBI
during
cerebellar-tACS.
θ-tACS
decreased
movement
regularity
tapping
task
increased
duration
pointing
compared
to
sham-
γ-tACS.
Additionally,
effectiveness
(greater
inhibition).
The
effect
rhythm
correlated
with
less
corresponded
greater
CBI.
Cerebellar-tACS
θ
frequency
modulates
cerebellar-related
behavior
this
is,
least
part,
mediated
inhibitory
output
onto
M1.
may
be
due
modulation
neurons
that
resonate
rhythm.
These
findings
contribute
a
better
understanding
physiological
mechanisms
control
provide
new
evidence
non-invasive
brain
stimulation.
Brain,
Journal Year:
2024,
Volume and Issue:
147(10), P. 3325 - 3343
Published: July 11, 2024
Concomitant
Alzheimer's
disease
(AD)
pathology
is
a
frequent
event
in
the
context
of
Lewy
body
(LBD),
occurring
approximately
half
all
cases.
Evidence
shows
that
LBD
patients
with
AD
copathology
show
an
accelerated
course,
greater
risk
cognitive
decline
and
overall
poorer
prognosis.
However,
LBD-AD
cases
may
heterogeneous
motor
non-motor
phenotypes
higher
dementia
and,
consequently,
be
not
rarely
misdiagnosed.
In
this
review,
we
summarize
current
understanding
by
discussing
synergistic
effects
neuropathological
changes
their
clinical
relevance.
Furthermore,
provide
extensive
overview
neuroimaging
fluid
biomarkers
under
assessment
for
use
possible
diagnostic
prognostic
values.
can
predicted
vivo
means
CSF,
MRI
PET
markers,
whereas
most
promising
technique
to
date
identifying
different
biological
tissues
α-synuclein
seed
amplification
assay.
Pathological
imaging
CSF
are
associated
likelihood
but
do
always
mirror
severity
as
pure
AD.
Implementing
blood-based
might
allow
faster
screening
copathology,
thus
improving
sensitivity
LBD-AD.
Finally,
discuss
literature
on
novel
candidate
being
exploited
investigate
other
aspects
neurodegeneration,
such
neuroaxonal
injury,
glial
activation
synaptic
dysfunction.
The
thorough
characterization
should
taken
into
account
when
considering
differential
diagnoses
syndromes,
evaluation
individual
level,
guide
symptomatic
disease-modifying
therapies.